Kairos Minerals shapes up as impressive gold and lithium play

|

Published 07-JUN-2017 11:51 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

After releasing impressive drilling results from the company’s Mt York gold lithium project in the Pilbara region of Western Australia just last week, Kairos Minerals (ASX:KAI) brought overseas investors up-to-date with the group’s story at the 121 Mining Conference in New York.

One of KAI’s key attractions, particularly as a junior explorer is its dual asset status. The company has the promising Roe Hills gold project situated in a highly prospective area 120 kilometres East of Kalgoorlie.

The company’s landholding of more than 300 square kilometres adjoins prominent projects being operated by Breaker Resources (ASX: BRB) and Silver Lake Resources (ASX: SLR).

The former released further promising high grade drilling results last week which should see it continue to upgrade the mining potential of the 2.2 kilometre long Bombora gold discovery. This resulted in the company’s shares spiking 10% to a new 12 month high.

However, it should be noted that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

KAI has recorded impressive results from Phase 1 reconnaissance drilling, confirming significant gold mineralisation at all three key prospect areas tested at Roe Hills. Details of the results are listed below.

Management noted that drilling indicates the potential for Roe Hills to host significant gold mineralisation along a largely untested prospective strike length of more than 40 kilometres.

KAI also views Roe Hills as a potential cobalt opportunity. A review of historical data has revealed near surface cobalt mineralisation at the ROE 1 prospect with anomalous cobalt identified over a total strike distance of circa 7.5 kilometres.

Mt York drilling results provide foundation for gold and lithium exploration

In tandem with Roe Hills, KAI is progressing the Mt York gold and lithium project. In October 2016, KAI delivered an upgraded Indicated and Inferred Resource for the Main Hill and Breccia Hill deposits at the Mt York project.

This resulted in a near doubling of the resource to just over 250,000 ounces with all deposits remaining open along strike and at depth within well-defined mineralised zones, providing rapid resource expansion opportunities.

Management announced last week that all final assay results from a maiden gold focused drilling program had been received. These included robust grades and relatively wide intersections. Preparations are underway for the next phase of exploration at the project which will include further investigation of new priority targets.

What makes KAI’s Mt York project an interesting prospect is its proven performance when operated as the Lynas gold mine. As indicated below, the conditions are far more favourable today in terms of the economic viability of the project, and there appears to be the potential to produce far more ore than was the case between 1994 and 1998.

tags

GOLD


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X